These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 14664468

  • 1. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A, Dehmeshki J, Peters KR, Griffin CM, Brex PA, Silver N, Ciccarrelli O, Chard DT, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
    [Abstract] [Full Text] [Related]

  • 2. [Diffusion tensor imaging of the normal-appearing brain tissue in relapsing-remitting multiple sclerosis].
    Yu CS, Li KC, Lin FC, Jiang TZ, Sun H, Chen B.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1260-4. PubMed ID: 16796886
    [Abstract] [Full Text] [Related]

  • 3. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mesaros S, Rocca M, Sormani M, Valsasina P, Markowitz C, De Stefano N, Montalban X, Barkhof F, Ranjeva J, Sailer M, Kappos L, Comi G, Filippi M.
    Mult Scler; 2010 Mar 16; 16(3):325-31. PubMed ID: 20086023
    [Abstract] [Full Text] [Related]

  • 4. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    Neuroradiology; 2001 Apr 16; 43(4):272-8. PubMed ID: 11338408
    [Abstract] [Full Text] [Related]

  • 5. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study.
    Filippi M, Inglese M, Rovaris M, Sormani MP, Horsfield P, Iannucci PG, Colombo B, Comi G.
    Neurology; 2000 Oct 10; 55(7):940-6. PubMed ID: 11061248
    [Abstract] [Full Text] [Related]

  • 6. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S, Enzinger C, Ropele S, Wallner M, Fazekas F.
    Mult Scler; 2008 Mar 10; 14(2):205-11. PubMed ID: 17986507
    [Abstract] [Full Text] [Related]

  • 7. A magnetization transfer histogram study of normal-appearing brain tissue in MS.
    Tortorella C, Viti B, Bozzali M, Sormani MP, Rizzo G, Gilardi MF, Comi G, Filippi M.
    Neurology; 2000 Jan 11; 54(1):186-93. PubMed ID: 10636146
    [Abstract] [Full Text] [Related]

  • 8. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP.
    Brain; 2006 Aug 11; 129(Pt 8):2008-16. PubMed ID: 16815879
    [Abstract] [Full Text] [Related]

  • 9. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis.
    Rovaris M, Bozzali M, Santuccio G, Iannucci G, Sormani MP, Colombo B, Comi G, Filippi M.
    J Neurol Neurosurg Psychiatry; 2000 Dec 11; 69(6):723-7. PubMed ID: 11080222
    [Abstract] [Full Text] [Related]

  • 10. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Rudick RA, Lee JC, Simon J, Fisher E.
    Ann Neurol; 2006 Aug 11; 60(2):236-42. PubMed ID: 16786526
    [Abstract] [Full Text] [Related]

  • 11. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
    Fox RJ, Fisher E, Tkach J, Lee JC, Cohen JA, Rudick RA.
    Mult Scler; 2005 Apr 11; 11(2):140-5. PubMed ID: 15794385
    [Abstract] [Full Text] [Related]

  • 12. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, Ourselin S, Miller DH, Chard DT.
    Mult Scler; 2014 Sep 11; 20(10):1322-30. PubMed ID: 24552746
    [Abstract] [Full Text] [Related]

  • 13. T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis.
    Griffin CM, Dehmeshki J, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2002 May 11; 8(3):211-6. PubMed ID: 12120692
    [Abstract] [Full Text] [Related]

  • 14. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
    Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R, Zivadinov R.
    J Neurol; 2010 Jan 11; 257(1):63-71. PubMed ID: 19633967
    [Abstract] [Full Text] [Related]

  • 15. Cervical cord lesion load is associated with disability independently from atrophy in MS.
    Kearney H, Altmann DR, Samson RS, Yiannakas MC, Wheeler-Kingshott CA, Ciccarelli O, Miller DH.
    Neurology; 2015 Jan 27; 84(4):367-73. PubMed ID: 25540312
    [Abstract] [Full Text] [Related]

  • 16. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.
    Davies GR, Ramió-Torrentà L, Hadjiprocopis A, Chard DT, Griffin CM, Rashid W, Barker GJ, Kapoor R, Thompson AJ, Miller DH.
    J Neurol Neurosurg Psychiatry; 2004 Jul 27; 75(7):998-1002. PubMed ID: 15201359
    [Abstract] [Full Text] [Related]

  • 17. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS.
    Filippi M, Bozzali M, Horsfield MA, Rocca MA, Sormani MP, Iannucci G, Colombo B, Comi G.
    Neurology; 2000 Jan 11; 54(1):207-13. PubMed ID: 10636149
    [Abstract] [Full Text] [Related]

  • 18. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA.
    Mult Scler; 2007 Jul 11; 13(6):708-16. PubMed ID: 17613597
    [Abstract] [Full Text] [Related]

  • 19. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
    Rudick RA, Fisher E, Lee JC, Duda JT, Simon J.
    Mult Scler; 2000 Dec 11; 6(6):365-72. PubMed ID: 11212130
    [Abstract] [Full Text] [Related]

  • 20. Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
    Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B.
    PLoS One; 2014 Dec 11; 9(3):e91098. PubMed ID: 24625687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.